Modulating neutrophil extracellular traps for wound healing

Area of Science:

• Biomaterials Science
• Wound Healing Research
• Immunology

Background:

• Diabetic microenvironments promote neutrophil extracellular trap (NET) formation, a process mediated by peptidylarginine deiminase 4 (PAD4).
• Increased PAD4-mediated NETosis contributes to impaired wound healing in diabetic patients.
• Neutrophil extracellular traps (NETs) degrade neutrophils, hindering early inflammatory responses crucial for healing.

Purpose of the Study:

• To develop an alginate-GelMa hydrogel scaffold for delivering a PAD4 inhibitor.
• To investigate the hypothesis that inhibiting PAD4 can enhance wound healing in diabetic conditions.
• To evaluate the scaffold's ability to modulate NETosis and improve wound healing efficacy.

Main Methods:

• Development and characterization of an alginate-GelMa hydrogel scaffold incorporating a PAD4-inhibiting tripeptide (Thr-Asp-F-amidine).
• Assessment of neutrophil-scaffold interactions, including NETosis and biomarker release.
• In vitro cell migration assays and in vivo wound healing studies using a diabetic rat model.

Main Results:

• The developed scaffold demonstrated favorable physicochemical and biological properties.
• A significant reduction in NETosis was observed in the presence of the PAD4 inhibitor within the scaffold.
• In vivo studies confirmed the scaffold's efficacy in improving wound healing in diabetic rats.

Conclusions:

• The novel hydrogel scaffold effectively delivers a PAD4 inhibitor, successfully modulating NETosis.
• This approach offers a promising strategy for enhancing wound healing in diabetic individuals.
• The study highlights a potential therapeutic system for managing diabetic wound complications.